Topic: Trial Schedule

2 chapters across the catalog

Del Bigtree discusses a significant proposed reduction in the U.S. childhood vaccine schedule, moving toward a model similar to Denmark's. The plan involves reducing the number of shots from 54 to approximately 23 and requiring rigorous double-blind placebo safety trials. Bigtree notes that Moderna CEO Stéphane Bancel recently cited this regulatory pressure as a reason for halting certain phase three vaccine trials.

Attorney Robert Barnes joins the discussion to analyze the potential timing of a New York trial, suggesting it could take anywhere from six to eighteen months. Barnes argues that if a local DA can effectively remove a President from office through litigation, it creates a massive constitutional crisis that the Supreme Court may need to resolve. He emphasizes that Trump is exposing the deep state's weaponization of the criminal justice system.